Immunogenicity of SARS inactivated vaccine in BALB/c mice

Severe acute respiratory syndrome (SARS) is a serious infectious threat to public health. To create a novel trial vaccine and evaluate its potency, we attempted to generate a SARS inactivated vaccine using SARS coronavirus (SARS-CoV) strain F69 treated with formaldehyde and mixed with Al(OH)(3). Thr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Immunol Lett
Autors principals: Xiong, Sheng, Wang, Yi-Fei, Zhang, Mei-Ying, Liu, Xin-Jian, Zhang, Chuan-Hai, Liu, Shi-Sheng, Qian, Chui-Wen, Li, Jiu-Xiang, Lu, Jia-Hai, Wan, Zhuo-Yue, Zheng, Huan-Yin, Yan, Xin-Ge, Meng, Min-Jie, Fan, Jiang-lin
Format: Artigo
Idioma:Inglês
Publicat: Elsevier B.V. 2004
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7112924/
https://ncbi.nlm.nih.gov/pubmed/15388253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imlet.2004.06.014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars